---
title: Ms Fiona Pearce
permalink: /ms-fiona-pearce/
variant: tiptap
description: ""
image: /images/Bio/PPI Advisory Panel/Fiona_Pearce_600x400.jpg
third_nav_title: PPI Advisory Panel
---
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 50%;" height="auto" width="100%" alt="" src="/images/Bio/PPI Advisory Panel/Fiona_Pearce_600x400.jpg">
</div>
<p>Ms Fiona Pearce is a Senior Advisor to the Agency for Care Effectiveness
(ACE), Singapore’s national HTA agency. As one of ACE’s founding staff,
she was responsible for developing the HTA methods and processes which
the agency uses to evaluate drugs and vaccines to inform national funding
decisions. She was also involved in establishing Singapore’s national Rare
Disease Fund in 2019, which provides long-term, financial support to patients
with rare genetic conditions, and more recently, has established the Consumer
Engagement and Education (CEE) workstream to encourage patient involvement
in ACE’s work.&nbsp;</p>
<p>She holds several appointments on different advisory boards in Singapore
and is the Co-Chair of the HTAi Patient and Citizen Involvement in HTA
Interest Group (PCIG).&nbsp;&nbsp;</p>
<p>Prior to joining ACE, Fiona was a Technical Advisor at the National Institute
for Health and Care Excellence (NICE), providing technical leadership on
appraisals of medicines within the National Health Service (NHS) in England.
She has also worked for the Cochrane Collaboration (renal group) in Australia
and in the private sector in various market access functions in Australia
and across the Asia-Pacific region.&nbsp;&nbsp;</p>